REAL-WORLD EXPERIENCE WITH AN IL-17A BLOCKER IN BIOLOGIC-NAIVE AND BIOLOGIC-EXPERIENCED RADIOGRAPHIC AND NON-RADIOGRAPHIC AXSPA PATIENTS

被引：0
|
作者：
Booth, Nicola [1 ]
Hill, Julie [2 ]
Leage, Soyi Liu [2 ]
Sapin, Christophe [2 ]
Holdsworth, Elizabeth [1 ]
Antonelli, Silvia [2 ]
机构：
[1] Adelphi Real World, Bollington, England
[2] Eli Lily & Co, Indianapolis, IN USA
来源：
RHEUMATOLOGY | 2020年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P278
引用
收藏
页码：128 / 128
页数：1
相关论文
共 50 条
  • [1] Response and radiographic progression in biologic-naive and biologic-experienced patients with rheumatoid arthritis treated with sirukumab
    Thorne, C.
    Karpouzas, G.
    Takeuchi, T.
    Sheng, S.
    Xu, W.
    Xu, S.
    Kurrasch, R.
    Fei, K.
    Hsu, B.
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2016, 45 : 23 - 24
  • [2] RESPONSE AND RADIOGRAPHIC PROGRESSION IN BIOLOGIC-NAIVE AND BIOLOGIC-EXPERIENCED PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH SIRUKUMAB
    Thorne, C.
    Karpouzas, G.
    Takeuchi, T.
    Sheng, S.
    Xu, W.
    Xu, S.
    Kurrasch, R.
    Fei, K.
    Hsu, B.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 723 - 723
  • [3] Real-World Use of Secukinumab Among Biologic-NaiVe and Biologic-Experienced Patients with Ankylosing Spondylitis in the United States
    Oelke, Kurt R.
    Garg, Rahul
    Li, Yunfeng
    Liu, Xing
    Zhou, Huanxue
    Park, Yujin
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [4] Real world use of ixekizumab is associated with reductions in concomitant medications among biologic-experienced or biologic-naive patients with psoriasis
    Wu, Jashin J.
    Zhu, Baojin
    Burge, Russel
    Goldblum, Orin
    Choong, Casey
    Edson-Heredia, Emily
    Amato, David
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB114 - AB114
  • [5] Efficacy and safety of bimekizumab in real-world psoriasis management: data from patients who are biologic-naive vs. biologic-experienced
    Megna, Matteo
    Ruggiero, Angelo
    Torta, Ginevra
    Martora, Fabrizio
    Bianco, Mariateresa
    Potestio, Luca
    [J]. CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2024, 49 (10) : 1186 - 1189
  • [6] Real-World Effectiveness and Safety of Subcutaneous Abatacept in Biologic-Naive vs. Biologic-Experienced RA Patients: The Abatacept Best Care Study
    Haraoui, Boulos
    Pope, Janet
    Fortin, Isabelle
    Rampakakis, Emmanouil
    Sampalis, John
    Romeyer, Francoise
    Atallah, Joseph
    Bessette, Louis
    [J]. JOURNAL OF RHEUMATOLOGY, 2018, 45 (07) : 1054 - 1054
  • [7] Real-World Effectiveness and Safety of Subcutaneous Abatacept in Biologic-Naive Vs. Biologic-Experienced RA Patients: The Abatacept Best Care Study
    Haraoui, B.
    Pope, Janet E.
    Fortin, Isabelle
    Rampakakis, Emmanouil
    Sampalis, John S.
    Romeyer, Francoise
    Atallah, Joseph
    Bessette, Louis
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [8] Secukinumab Therapy in Biologic-naive vs. Biologic-experienced Patients: Real-world Effectiveness, Persistence and Safety Results from the Rheumatic Diseases Portuguese Registry
    Azevedo, Soraia
    Tavares-Costa, Jose
    Laires, Pedro
    Garcia, Salome
    Nero, Patricia
    Pestana, Jorge
    Martins-Martinho, Joana
    Silva, Ana Bento
    Rodrigues, Joana
    Sequeira, Graca
    Costa, Emanuel
    Santos, Filipe Cunha
    Furtado, Carolina
    Santos, Bernardo
    Raposo, Ana
    Saraiva, Liliana
    Samoes, Beatriz
    Barcelos, Filipe
    Santos, Maria Jose
    Santos, Helena
    [J]. ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3829 - 3831
  • [9] Asthma outcomes with benralizumab in biologic-naive and biologic-experienced patients with severe eosinophilic asthma (SEA) in an integrated analysis of the real-world XALOC-1 study
    Nair, P.
    Pelaia, G.
    Emmanuel, B.
    Tran, T. N.
    Shih, V.
    Watt, M.
    Kayaniyil, S.
    Boarino, S.
    Nuevo, J.
    Pardal, M.
    Cohen, D.
    Shavit, A.
    Kwiatek, J.
    Loureiro, C. Chaves
    Padilla-Galo, A.
    Jackson, D.
    [J]. ALLERGY, 2023, 78 : 252 - 253
  • [10] REAL WORLD (RW) EXPERIENCE WITH AN ANTI-IL-17A INHIBITOR IN BIOLOGIC NAIVE AND BIOLOGIC EXPERIENCED PSORIATIC ARTHRITIS (PSA) PATIENTS
    Moon, R.
    Hill, J.
    Booth, N.
    Lobosco, S.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 382 - 383
12345